{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:35:48Z","timestamp":1760142948910,"version":"build-2065373602"},"reference-count":38,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Thymic epithelial tumors (TET) consist of thymomas, thymic carcinoma (TC), and neuroendocrine tumors of the thymus (NECTT). Genetic and epigenetic alterations in TET have been the focus of recent research. In the present study, genome-wide screening was performed on aberrantly methylated CpG islands in TET, and this identified neuronal pentraxin 2 (NTPX2) as a significantly hypermethylated CpG island in TC relative to thymomas. NPTX2 is released from pre-synaptic cells in response to neuronal activity\/seizure, and plays a role in host immunity and acute inflammation. TET samples were obtained from 38 thymomas, 25 TC, and 6 NECTT. The DNA methylation, mRNA, and protein expression levels of NPTX2 were examined. The DNA methylation rate of the NPTX2 gene was significantly higher in TC than in the normal thymus and thymomas, except B3. The mRNA expression level of NPTX2 was lower in TC than in the normal thymus. An inverse relationship was observed between mRNA expression levels and methylation levels. Relapse-free survival was shorter in patients with high NPTX2 DNA methylation levels than in those with low DNA methylation levels. NECTT showed very high mRNA and protein expression levels and low DNA methylation levels of NPTX2. NPTX2 may function as a tumor suppressor in TC, and have an oncogenic function in NECTT.<\/jats:p>","DOI":"10.3390\/cancers16020329","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T12:56:33Z","timestamp":1704977793000},"page":"329","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Aberrant DNA Methylation of NPTX2 as an Indicator of Malignant Behavior in Thymic Epithelial Tumors"],"prefix":"10.3390","volume":"16","author":[{"given":"Kazuya","family":"Kondo","sequence":"first","affiliation":[{"name":"Department of Oncological Medical Services, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8509, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoka","family":"Muguruma","sequence":"additional","affiliation":[{"name":"Department of Oncological Medical Services, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8509, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiho","family":"Soejima","sequence":"additional","affiliation":[{"name":"Department of Oncological Medical Services, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8509, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Takai","sequence":"additional","affiliation":[{"name":"Department of Oncological Medical Services, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8509, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kenzaki","sequence":"additional","affiliation":[{"name":"Department of Chest and Breast Surgical Oncology, Takamatsu Red Cross Hospital, Takamatsu 760-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Kawakita","sequence":"additional","affiliation":[{"name":"Department of Thoracic, Endocrine Surgery and Oncology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Toba","sequence":"additional","affiliation":[{"name":"Department of Thoracic, Endocrine Surgery and Oncology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Takizawa","sequence":"additional","affiliation":[{"name":"Department of Thoracic, Endocrine Surgery and Oncology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11748-014-0420-z","article-title":"Therapy for thymic epithelial tumors","volume":"62","author":"Kondo","year":"2014","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"ref_2","unstructured":"Bosman, F.T., Jaffe, E.S., Lakhani, S.R., and Ohgaki, H. (2015). World Health Organization Classification of Tumours, IARC Press. [4th ed.]."},{"key":"ref_3","unstructured":"Shimosato, Y., Mukai, K., and Matsuno, Y. (2010). AFIP Atlas of Tumor Pathology, Series 4, Armed Forces Institute of Pathology."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Lin, D., Aramini, B., Yang, F., Chen, X., Wang, X., Wu, L., Huang, W., and Fan, J. (2023). Thymoma and Thymic Carcinoma: Surgical Resection and Multidisciplinary Treatment. Cancers, 15.","DOI":"10.3390\/cancers15071953"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: A clinical study of 1320 patients from Japan","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann. Thorac. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3760\/cma.j.issn.0366-6999.20130177","article-title":"Thymoma: Current diagnosis and treatment","volume":"126","author":"Detterbeck","year":"2013","journal-title":"Chin. Med. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.lungcan.2018.01.025","article-title":"Optimal surgical approach to thymic malignancies: New trends challenging old dogmas","volume":"118","author":"Ruffini","year":"2018","journal-title":"Lung Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1177\/1078155219852758","article-title":"The role of targeted therapy in thymic carcinoma","volume":"25","author":"Krishnan","year":"2019","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1470-2045(14)71181-7","article-title":"Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: An open-label phase 2 trial","volume":"16","author":"Thomas","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1470-2045(18)30062-7","article-title":"Pembrolizumab in patients with thymic carcinoma: A single-arm, single-centre, phase 2 study","volume":"19","author":"Giaccone","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1470-2045(20)30162-5","article-title":"Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): A multicentre, phase 2 trial","volume":"21","author":"Sato","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"Cancer Genome Atlas Network: The integrated genomic landscape of thymic epithelial tumors","volume":"33","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/carcin\/bgx094","article-title":"The genomic and epigenomic landscape in thymic carcinoma","volume":"38","author":"Saito","year":"2017","journal-title":"Carcinogenesis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s12253-016-0144-8","article-title":"Molecular profiling of thymoma and thymic carcinoma: Genetic differences and potential novel therapeutic targets","volume":"23","author":"Enkner","year":"2017","journal-title":"Pathol. Oncol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ng.3016","article-title":"A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors","volume":"46","author":"Petrini","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101627","DOI":"10.1016\/j.esmoop.2023.101627","article-title":"Genomic characterization of thymic epithelial tumors in a real-world dataset","volume":"11","author":"Kurokawa","year":"2023","journal-title":"ESMO Open"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.lungcan.2008.07.015","article-title":"Aberrant methylation of tumour-related genes in thymic epithelial tumours","volume":"64","author":"Hirose","year":"2009","journal-title":"Lung Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.lungcan.2013.12.004","article-title":"Methylation and expression profiles of MGMT gene in thymic epithelial tumors","volume":"83","author":"Mokhtar","year":"2014","journal-title":"Lung Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.lungcan.2017.05.019","article-title":"Frequent silencing of RASSF1A by DNA methylation in thymic neuroendocrine tumours","volume":"111","author":"Kajiura","year":"2017","journal-title":"Lung Cancer"},{"key":"ref_20","first-page":"315","article-title":"DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma","volume":"56","author":"Kishibuchi","year":"2020","journal-title":"Int. J. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3892\/ol.2021.12744","article-title":"GAD1 expression and its methylation as indicators of malignant behavior in thymic epithelial tumors","volume":"21","author":"Soejima","year":"2021","journal-title":"Oncol. Lett."},{"key":"ref_22","first-page":"22190","article-title":"Interleukin-1-inducible genes in endothelial cells","volume":"267","author":"Breviarios","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1042\/bj2660283","article-title":"Mouse C-reactive protein. generation of cDNA clones, structural analysis and induction of MRNA during inflammation","volume":"266","author":"Whitehead","year":"1990","journal-title":"Biochem. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1042\/bj2700553","article-title":"Rat serum amyloid P component","volume":"270","author":"Dowton","year":"1990","journal-title":"Biochem. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.4049\/jimmunol.150.5.1804","article-title":"TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentraxin family of acute phase proteins","volume":"150","author":"Lee","year":"1993","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(95)90308-9","article-title":"Neuronal pentraxin, a secreted protein with homology to acute phase proteins of the immune system","volume":"14","author":"Schlimgen","year":"1995","journal-title":"Neuron"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1523\/JNEUROSCI.16-08-02463.1996","article-title":"Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity","volume":"16","author":"Tsui","year":"1996","journal-title":"J. Neurosci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3389\/fncel.2019.00575","article-title":"The Role of Neuronal Pentraxin 2 (NP2) in Regulating Glutamatergic Signaling and Neuropathology","volume":"8","author":"Chapman","year":"2020","journal-title":"Front. Cell Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.neuron.2015.02.020","article-title":"Pentraxins coordinate excitatory synapse maturation and circuit integration of parvalbumin interneurons","volume":"85","author":"Pelkey","year":"2015","journal-title":"Neuron"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00401-007-0309-3","article-title":"Neuronal pentraxin II is highly upregulated in Parkinson\u2019s disease and a novel component of Lewy bodies","volume":"115","author":"Moran","year":"2008","journal-title":"Acta Neuropathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1158\/0008-5472.CAN-15-0649","article-title":"The neuronal pentraxin-2 pathway is an unrecognized target in human neuroblastoma, which also offers prognostic value in patients","volume":"75","author":"Bartolini","year":"2015","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1158\/0008-5472.CAN-14-0210","article-title":"Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4","volume":"74","author":"Radisky","year":"2014","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"S1710","DOI":"10.1097\/JTO.0b013e31821e8cff","article-title":"The Masaoka-Koga stage classification for thymic malignancies: Clarification and definition of terms","volume":"6","author":"Detterbeck","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1007\/s10620-012-2202-8","article-title":"Neuronal pentraxin II (NPTX2) is frequently down-regulated by promoter hypermethylation in pancreatic cancers","volume":"57","author":"Zhang","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1007\/s11033-010-0632-y","article-title":"The neuronal Pentraxin II gene (NPTX2) inhibit proliferation and invasion of pancreatic cancer cells in vitro","volume":"38","author":"Zhang","year":"2011","journal-title":"Mol. Biol. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1158\/0008-5472.CAN-13-0298","article-title":"DNA methylation prognostic signature of glioblastoma: Identification of NPTX2-PTEN-NF-\u03baB nexus","volume":"73","author":"Shukla","year":"2013","journal-title":"Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41419-019-1467-7","article-title":"NPTX2 promotes colorectal cancer growth and liver metastasis by the activation of the canonical Wnt\/\u03b2-catenin pathway via FZD6","volume":"10","author":"Xu","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_38","unstructured":"(2018, August 30). Human Protein Atlas. Available online: https:\/\/www.proteinatlas.org\/ENSG00000106236-NPTX2\/pathology."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/2\/329\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:45:03Z","timestamp":1760103903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/2\/329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["cancers16020329"],"URL":"https:\/\/doi.org\/10.3390\/cancers16020329","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2024,1,11]]}}}